Low power laser treatment of the retina ameliorates neovascularisation in a transgenic mouse model of retinal neovascularisation

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 791-800

  Yu, Paula K ^a   Cringle, Stephen J ^a   McAllister, Ian L ^a   Yu, Dao Yi ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

FITC dextran; oxygen; PEDF; photocoagulation; VEGF

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ELECTRORETINOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; LOW LEVEL LASER THERAPY; MOUSE; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; TREATMENT OUTCOME; VISION;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; EYE PROTEINS; FLUORESCEIN ANGIOGRAPHY; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; LASER THERAPY, LOW-LEVEL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE GROWTH FACTORS; PHOTORECEPTOR CELLS, VERTEBRATE; PROMOTER REGIONS, GENETIC; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RHODOPSIN; SERPINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION DISORDERS; VISION, OCULAR;

EID: 70349456642     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.07.004     Document Type: Article

References (41)

1. Aiello L.M., Beetham W.P., Balodimos M.C., Chazan B.I., and Bradley R.F. Ruby laser photocoagulation in treatment of diabetic proliferating retinopathy. Preliminary Report. In: Goldberg M.F., and Fine S.L. (Eds). Symposium: Treatment of Diabetic Retinopathy (1968), U.S. Government Printing Office 437-463 (Chapter 35)
2. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N., and King G.L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331 (1994) 1480-1487
3. Algvere P.V., Hallnas K., Dafgard E., and Hoog A. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 228 (1990) 461-466
4. Arden G.B. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br. J. Ophthalmol. 85 (2001) 366-370
5. Arnarsson A., and Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 41 (2000) 877-879
6. Bandello F., Brancato R., Menchini U., Virgili G., Lanzetta P., Ferrari E., and Incorvaia C. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. Semin. Ophthalmol. 16 (2001) 12-18
7. Boulton M., Foreman D., Williams G., and McLeod D. VEGF localisation in diabetic retinopathy. Br. J. Ophthalmol. 82 (1998) 561-568
8. Branch retinal vein occlusion study group. Argon laser photocoagulation for macular oedema in branch vein occlusion. Am. J. Ophthalmol. 98 (1984) 271-282
9. Campochiaro P.A., and Hackett S.F. Ocular neovascularization: a valuable model system. Oncogene 22 (2003) 6537-6548
10. Capoferri C., Baqini M., Chizzoli A., Pece A., and Brancato R. Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers. Graefes Arch. Clin. Exp. Ophthalmol. 228 (1990) 232-236
11. D'Amato R., Wesolowski E., and Hodgson Smith L.E. Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc. Res. 46 (1993) 135-142
12. Dalke C., Loster J., Fuchs H., Gailus-Durner V., Soewarto D., Favor J., Neuhauser-Klaus A., Pretsch W., Gekeler F., Shinoda K., Zrenner E., Meitinger T., Hrabe de Angelis M., and Graw J. Electroretinography as a screening method for mutations causing retinal dysfunction in mice. Invest. Ophthalmol. Vis. Sci. 45 (2004) 601-609
13. Early treatment diabetic retinopathy study research group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98 (1991) 766-785
14. Fong D.S., Strauber S.F., Aiello L.P., Beck R.W., Callanan D.G., Danis R.P., Davis M.D., Feman S.S., Ferris F., Friedman S.M., Garcia C.A., Glassman A.R., Han D.P., Le D., Kollman C., Lauer A.K., Recchia F.M., and Solomon S.D. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch. Ophthalmol. 125 (2007) 469-480
15. Hattenbach L.O., Beck K.F., Pfeilschifter J., Koch F., Ohrloff C., and Schacke W. Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells. Ophthalmic Res. 37 (2005) 341-346
16. Ida H., Tobe T., Nambu H., Matsumura M., Uyama M., and Campochiaro P.A. RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5430-5437
17. Landers M.B., Stefansson E., and Wolbarsht M.L. Panretinal photocoagulation and retinal oxygenation. Retina 2 (1982) 167-175
18. Mori K., Gehlbach P., Ando A., McVey D., Wei L., and Campochiaro P.A. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 2002 (2002) 2428-2434
19. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., and Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1168-1175
20. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., and Matsumura M. Pigment epithelium derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am. J. Ophthalmol. 132 (2001) 378-382
21. Okamoto N., Tobe T., Hackett S.F., Ozaki H., Vinores M.A., LaRochelle W., Zack D.J., and Campochiaro P.A. Transgenic mice with increased expression of vascular endothelial growth factor in the retina. Am. J. Pathol. 151 (1997) 281-291
22. Ozaki H., Yu A.Y., Della N., Ozaki K., Luna J.D., Yamada H., Hackett S.F., Okamoto N., Zack D.J., Semenza G.L., and Campochiaro P.A. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest. Ophthalmol. Vis. Sci. 40 (1999) 182-189
23. Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full-versus mild-scatter coagulation. Int. Ophthalmol. 22 (1998) 313-319
24. Pournaras C.J., Tsacopoulos M., Strommer K., Gilodi N., and Leuenberger P.M. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97 (1990) 1329-1333
25. Seiberth V., and Alexandridis E. Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots. Ophthalmologica 202 (1991) 10-17
26. Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol. Scand. 79 (2001) 435-440
27. Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv. of Ophthalmol 51 (2006) 364-380
28. Stefansson E., Hatchell D.L., Fisher B.L., Sutherland F.S., and Machemer R. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am. J. Ophthalmol. 101 (1986) 657-664
29. Stefansson E., Landers M.B., and Wolbarsht M.L. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans. Am. Ophthalmol. Soc. LXXIX (1981) 307-334
30. Stone J., Maslim J., Valter-Kocsi K., Mervin K., Bowers F., Chu Y., Barnett N., Provis J., Lewis G., Fisher S.K., Bisti S., Gargini C., Cervetto L., Merin S., and Pe'er J. Mechanisms of photoreceptor death and survival in mammalian retina. Prog. Retin. Eye Res. 18 (1999) 689-735
31. Takagi H., King G.L., Ferrara N., and Aiello L.P. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1311-1321
32. The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy: diabetic Retinopathy Study Report no. 14. Int. Ophthalmol. Clin. 27 (1987) 239-253
33. Wolbarsht M.L., and Landers III M.B. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Ophthalmic Surg. 11 (1980) 235-245
34. Yu D.-Y., and Cringle S.J. Low oxygen consumption in the inner retina of the visual streak of the rabbit. Am. J. Physiol. (Heart C) 286 (2004) H419-H423
35. Yu D.-Y., and Cringle S.J. Oxygen distribution in the mouse retina. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1109-1112
36. Yu D.-Y., Cringle S.J., Alder V.A., and Su E.N. Intraretinal oxygen distribution in rats as a function of systemic blood pressure. Am. J. Physiol. 36 (1994) H2498-H2507
37. Yu D.-Y., Cringle S.J., and Su E.-N. Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia. Invest. Ophthalmol. Vis. Sci. (2005) 4728-4733
38. Yu D.-Y., Cringle S.J., Su E.-N., Yu P.K., Humayun M.S., and Dorin G. Laser induced changes in intraretinal oxygen distribution in pigmented rabbits. Invest. Ophthalmol. Vis. Sci. 46 (2005) 988-999
39. Yu D.-Y., Cringle S.J., Su E.N., and Yu P.K. Intraretinal oxygen levels before and after photoreceptor loss in the RCS rat. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3999-4006
40. Yu D.-Y., Cringle S.J., Valter K., Walsh N., Lee D., and Stone J. Photoreceptor death, trophic factor expression, retinal oxygen status and photoreceptor function in the P23H rat: stress and protection in a slow degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2013-2049
41. 2. Curr. Eye Res. 12 (1993) 809-825